Table of Contents
ISRN Radiology
Volume 2013, Article ID 627932, 9 pages
http://dx.doi.org/10.5402/2013/627932
Research Article

Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis

1The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
2Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
3Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
4The Johns Hopkins Hospital Comprehensive Neurofibromatosis Center, Department of Neurology, The Johns Hopkins Hospital, CRB II, Suite 1M16, 1550 Orleans Street, Baltimore, MD 21231, USA
5Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA
6Neurofibromatosis Clinic, Pappas Center for Neuro-Oncology, Massachusetts General Hospital, 55 Fruit Street, YAW 9, Boston, MA 02114, USA
7Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
8Pharmacology & Experimental Therapeutics Section, Pediatric Oncology Branch, NCI, CCR, Room 1-5750, 10 Center Drive, 10-CRC, MSC 1101, Bethesda, MD 20892, USA

Received 20 June 2013; Accepted 13 August 2013

Academic Editors: A. Labate and K. Tsuchiya

Copyright © 2013 Laura M. Fayad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. G. Gleeson, J. Moriarty, C. P. Shortt et al., “Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI),” Skeletal Radiology, vol. 38, no. 3, pp. 225–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. W. Goo, “Whole-body MRI of neuroblastoma,” European Journal of Radiology, vol. 75, no. 3, pp. 306–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gutzeit, A. Doert, J. M. Froehlich et al., “Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma,” Skeletal Radiology, vol. 39, no. 4, pp. 333–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Venkitaraman, G. J. R. Cook, D. P. Dearnaley et al., “Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer,” Journal of Medical Imaging and Radiation Oncology, vol. 53, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. E. Lecouvet, J. El Mouedden, L. Collette et al., “Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?” European Urology, vol. 62, no. 1, pp. 68–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ohlmann-Knafo, M. Kirschbaum, G. Fenzl, and D. Pickuth, “Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer: a prospective double-blinded study at two hospital centers,” RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren, vol. 181, no. 3, pp. 255–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Takenaka, Y. Ohno, K. Matsumoto et al., “Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDGPET/CT, and bone scintigraphy,” Journal of Magnetic Resonance Imaging, vol. 30, no. 2, pp. 298–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Jacobs, L. Pan, and K. J. Macura, “Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer,” Seminars in Roentgenology, vol. 44, no. 2, pp. 111–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. F. L. Van Meerbeeck, K. L. Verstraete, S. Janssens, and G. Mortier, “Whole body MR imaging in neurofibromatosis type 1,” European Journal of Radiology, vol. 69, no. 2, pp. 236–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. V.-F. Mautner, F. A. Asuagbor, E. Dombi et al., “Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1,” Neuro-Oncology, vol. 10, no. 4, pp. 593–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Jaremko, P. J. MacMahon, M. Torriani et al., “Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis,” Skeletal Radiology, vol. 41, no. 8, pp. 917–923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Cai, A. Kassarjian, M. A. Bredella et al., “Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images,” Radiology, vol. 250, no. 3, pp. 665–675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Plotkin, M. A. Bredella, W. Cai et al., “Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis,” PLoS ONE, vol. 7, no. 4, Article ID e35711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. H. El Khouli, M. A. Jacobs, S. D. Mezban et al., “Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging,” Radiology, vol. 256, no. 1, pp. 64–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Chen, J. Zhong, H. Wu, and N. Chen, “The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience,” Magnetic Resonance Imaging, vol. 30, no. 2, pp. 165–170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. K. De Paepe, C. Bevernage, F. De Keyzer et al., “6. 3 Tesla whole-body diffusion-weighted imaging (WB-DWI) for early treatment assessment and treatment prediction in lymphoma,” Cancer Imaging, pp. S178–S179, 2011. View at Publisher · View at Google Scholar
  17. J. Kalkmann, T. Lauenstein, and J. Stattaus, “Whole-body diffusion-weighted imaging in oncology: technical aspects and practical relevance,” Radiologe, vol. 51, no. 3, pp. 215–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. A. Karel'sckaia and G. G. Karmazanovskiǐ, “Diffusion weighted whole-body MRI,” Khirurgiia, vol. 8, no. 8, pp. 57–60, 2010. View at Google Scholar · View at Scopus
  19. T. C. Kwee, T. Takahara, M. A. Vermoolen, M. B. Bierings, W. P. Mali, and R. A. J. Nievelstein, “Whole-body diffusion-weighted imaging for staging malignant lymphoma in children,” Pediatric Radiology, vol. 40, no. 10, pp. 1592–1602, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. J. Lambregts, M. Maas, V. C. Cappendijk et al., “Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging,” European Journal of Cancer, vol. 47, no. 14, pp. 2107–2116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Lin, E. Itti, A. Luciani, C. Haioun, M. Meignan, and A. Rahmouni, “Whole-body diffusion-weighted imaging in lymphoma,” Cancer Imaging, vol. 10, pp. S172–178, 2010. View at Google Scholar · View at Scopus
  22. A. Luciani, C. Lin, P. Beaussart, P. Zerbib, C. Haioun, and A. Rahmouni, “Whole body functional MR imaging: hemato-oncologic applications,” Journal of Radiology, vol. 91, no. 3, pp. 375–380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Messiou and N. M. Desouza, “Diffusion weighted magnetic resonance imaging of metastatic bone disease: a biomarker for treatment response monitoring,” Cancer Biomarkers, vol. 6, no. 1, pp. 21–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Padhani, D.-M. Koh, and D. J. Collins, “Whole-body diffusion-weighted MR imaging in cancer: current status and research directions,” Radiology, vol. 261, no. 3, pp. 700–718, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Jacobs, R. Ouwerkerk, K. Petrowski, and K. J. MacUra, “Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer,” Topics in Magnetic Resonance Imaging, vol. 19, no. 6, pp. 261–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. A. Malayeri, R. H. El Khouli, A. Zaheer et al., “Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up,” Radiographics, vol. 31, no. 6, pp. 1773–1791, 2011. View at Google Scholar · View at Scopus
  27. D. Le Bihan, C. Poupon, A. Amadon, and F. Lethimonnier, “Artifacts and pitfalls in diffusion MRI,” Journal of Magnetic Resonance Imaging, vol. 24, no. 3, pp. 478–488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. W. Y. Chee, W. C. G. Peh, and T. W. H. Shek, “Pictorial essay: imaging of peripheral nerve sheath tumours,” Canadian Association of Radiologists Journal, vol. 62, no. 3, pp. 176–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kehrer-Sawatzki, L. Kluwe, C. Fünsterer, and V.-F. Mautner, “Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2,” Human Genetics, vol. 116, no. 6, pp. 466–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Kluwe, R. Nguyen, J. Vogt et al., “Internal tumor burden in neurofibromatosis Type I patients with large NF1 deletions,” Genes Chromosomes and Cancer, vol. 51, no. 5, pp. 447–451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. R. Padhani and A. Gogbashian, “Bony metastases: assessing response to therapy with whole-body diffusion MRI,” Cancer Imaging, pp. S129–S145, 2011. View at Publisher · View at Google Scholar
  32. C. Reischauer, J. M. Froehlich, D.-M. Koh et al., “Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps: initial observations,” Radiology, vol. 257, no. 2, pp. 523–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Lin, A. Luciani, K. Belhadj et al., “Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging,” Radiology, vol. 254, no. 2, pp. 521–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. E. Rittner, U. Baumann, F. Laenger, D. Hartung, H. Rosenthal, and K. Hueper, “Whole-body diffusion-weighted MRI in a case of Rosai-Dorfman disease with exclusive multifocal skeletal involvement,” Skeletal Radiology, vol. 41, no. 6, pp. 709–713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Akhbardeh and M. A. Jacobs, “Comparative analysis of nonlinear dimensionality reduction techniques for breast MRI segmentation,” Medical Physics, vol. 39, no. 4, pp. 2275–2289, 2012. View at Google Scholar